SCHEMBL19779877

SCHEMBL19779877

CCCCC(CCC)c1ncccc1/C=N/O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGF23 Q9GZV9 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ HPGD P15428 3/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ TSHR P16473 2/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ TLR8 Q9NR97 4/20 0.33
▸ USP2 O75604 2/20 0.33
▸ TLR7 Q9NYK1 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ LMNA P02545 2/20 0.33
▸ HTT P42858 2/20 0.33
▸ HSP90AA1 P07900 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ ALOX12 P18054 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ IDO1 P14902 1/20 0.32
▸ POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21884021 0.93 FGF23 (0.39) FGF23ALDH1A1HPGDMAPK1TSHR
SCHEMBL20621419 0.89 FGF23 (0.41) FGF23ALDH1A1HPGDMAPK1TSHR
SCHEMBL23492891 0.82 FGF23 (0.42) FGF23ALDH1A1HPGDMAPK1TSHR
SCHEMBL19880469 0.76 ALDH1A1 (0.49) FGF23ALDH1A1HPGDMAPK1TSHR
SCHEMBL19769027 0.76 ALDH1A1 (0.49) FGF23ALDH1A1HPGDMAPK1TSHR
SCHEMBL19779926 0.74 TLR8 (0.38) HPGDTLR8TLR7IDO1CYP1A2
SCHEMBL7086706 0.74 CYSLTR2 (0.40) FGF23ALDH1A1HPGDMAPK1TSHR
SCHEMBL23491215 0.74 KDM4E (0.36) FGF23MAPK1USP2KDM4ELMNA
SCHEMBL9761889 0.70 ALOX12 (0.45) ALDH1A1HPGDMAPK1TSHRHSD17B10
SCHEMBL21618542 0.70 CYP2D6 (0.34) TLR8TLR7KDM4ELMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180016252-A1 SOMATOSTATIN MODULATORS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2018-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180016252-A1 SOMATOSTATIN MODULATORS AND USES THEREOF SSTR5, SSTR2, SSTR4 FGF23 194/4885ALDH1A1 4626/4885HPGD 1517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback